Clinical Trials Browser

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × ruxolitinib × 30 days × Clear all

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive